EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+5.99%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$142M
AUM Growth
+$142M
(-0.15%)
Cap. Flow
+$4.05M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
51.56%
Holding
51
New
6
Increased
20
Reduced
15
Closed
5
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$4.01M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.16M |
| 3 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$2.61M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$2.6M |
| 5 |
MeiraGTx Holdings
MGTX
|
$2.57M |
Top Sells
| 1 |
Solid Biosciences
SLDB
|
$2.75M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$2.45M |
| 3 |
argenx
ARGX
|
$2.35M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$2.31M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$2.21M |
Sector Composition
| 1 | Healthcare | 50.39% |
| 2 | Financials | 32.94% |
| 3 | Consumer Discretionary | 8.74% |
| 4 | Industrials | 2.71% |
| 5 | Real Estate | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $37.2M | 26.22% |
117
| – | – |
|
2
JD.com
JD
$44.1B
| $12M | 8.48% |
397,528
| – | – |
|
|
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
| $4.01M | 2.82% |
+86,567
| New | +$4.01M |
|
|
4
Iovance Biotherapeutics
IOVA
$807M
| $3.21M | 2.26% |
131,041
-99,851
| -43% | -$2.45M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.16M | 2.22% |
+30,680
| New | +$3.16M |
|
|
RARX
6
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.94M | 2.07% |
97,916
-21,043
| -18% | -$633K |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $2.86M | 2.01% |
59,905
+9,147
| +18% | +$437K |
|
|
EIDX
8
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2.61M | 1.83% |
+83,836
| New | +$2.61M |
|
|
BPMC
9
DELISTED
Blueprint Medicines
BPMC
| $2.6M | 1.83% |
+27,551
| New | +$2.6M |
|
|
10
MeiraGTx Holdings
MGTX
$587M
| $2.57M | 1.81% |
+95,462
| New | +$2.57M |
|
|
AMRN
11
Amarin Corp
AMRN
$311M
| $2.56M | 1.8% |
132,255
-2,803
| -2% | -$54.3K |
|
|
GHDX
12
DELISTED
Genomic Health, Inc.
GHDX
| $2.5M | 1.76% |
42,966
+14,347
| +50% | +$834K |
|
13
Travere Therapeutics
TVTX
$1.56B
| $2.48M | 1.75% |
123,600
+12,973
| +12% | +$261K |
|
14
Wave Life Sciences
WVE
$1.53B
| $2.47M | 1.74% |
94,475
+31,041
| +49% | +$810K |
|
15
Neurocrine Biosciences
NBIX
$13.8B
| $2.45M | 1.72% |
29,020
+733
| +3% | +$61.9K |
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.45M | 1.72% |
645,583
+380,570
| +144% | +$1.44M |
|
17
Incyte
INCY
$16.5B
| $2.44M | 1.72% |
28,714
+196
| +0.7% | +$16.7K |
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $2.42M | 1.71% |
23,131
+5,499
| +31% | +$576K |
|
19
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.41M | 1.7% |
90,188
-12,398
| -12% | -$331K |
|
20
Amicus Therapeutics
FOLD
$2.34B
| $2.4M | 1.69% |
192,533
-16,321
| -8% | -$204K |
|
21
Heron Therapeutics
HRTX
$207M
| $2.4M | 1.69% |
129,020
+42,543
| +49% | +$791K |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.39M | 1.68% |
18,235
-194
| -1% | -$25.4K |
|
|
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.33M | 1.64% |
33,593
+225
| +0.7% | +$15.6K |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.25M | 1.58% |
26,278
+902
| +4% | +$77.3K |
|
|
ONC
25
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.21M | 1.55% |
17,807
-232
| -1% | -$28.8K |
|